Eco Animal Health keeps up momentum

Eco Animal Health keeps up momentum

Efforts to focus on selling its high-margin products have been paying off for Eco Animal Health (EAH), ensuring that profits outpace its rising revenues. The group posted record results, thanks to the growth of Aivlosin, its patented antibiotic used for treating disease in pigs and poultry.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now